Overview
Thomas Tipton practices practicing medicine in Porton, United Kingdom.
His clinical expertise encompasses Prolymphocytic Leukemia, Ebola Virus Disease, and Viral Hemorrhagic Fever.
He is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Thomas W. Tipton
Is Thomas W. Tipton a top-rated expert for Prolymphocytic Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Thomas W. Tipton is classified as an Experienced expert for Prolymphocytic Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Thomas W. Tipton participate in research or clinical trials?
Yes. Thomas W. Tipton has published 9 articles and abstracts on conditions like Prolymphocytic Leukemia. You can view a list of Thomas W. Tipton's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Ebola Virus DiseaseMr. Tipton isExperienced. Learn about Ebola Virus Disease.
- Prolymphocytic LeukemiaMr. Tipton isExperienced. Learn about Prolymphocytic Leukemia.
- Viral Hemorrhagic FeverMr. Tipton isExperienced. Learn about Viral Hemorrhagic Fever.